These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2481220)

  • 1. Custom-designed synthetic peptide immunoassays for distinguishing HIV type 1 and type 2 infections.
    Gnann JW; Smith LL; Oldstone MB
    Methods Enzymol; 1989; 178():693-714. PubMed ID: 2481220
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinction between HIV-1 and HIV-2 infection using novel synthetic lipopeptide conjugates as antigens in enzyme immunoassays.
    Böltz T; Hummel RP; Tröger W; Rübsamen-Waigmann H; Biesert L; Müller-Lantzsch N; Koch P; Bessler W; Jung G
    J Virol Methods; 1988 Dec; 22(2-3):173-82. PubMed ID: 2464607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of antibodies against HIV-1 and HIV-2 using "new antigens"].
    Miyakoshi H
    Nihon Rinsho; 1993 Sep; 51 Suppl():279-83. PubMed ID: 7505848
    [No Abstract]   [Full Text] [Related]  

  • 4. [Laboratory assessment of HIV infection and its sequelae].
    Grob PJ
    Ther Umsch; 1988 Sep; 45(9):593-603. PubMed ID: 2903571
    [No Abstract]   [Full Text] [Related]  

  • 5. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual HIV-1 and HIV-2 infection in West Africa supported by synthetic peptide analysis.
    Cot MC; Poulain M; Delagneau JF; Peeters M; Brun-Vezinet F
    AIDS Res Hum Retroviruses; 1988 Aug; 4(4):239-41. PubMed ID: 3207511
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.
    Gnann JW; McCormick JB; Mitchell S; Nelson JA; Oldstone MB
    Science; 1987 Sep; 237(4820):1346-9. PubMed ID: 2888192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Envelope cross-reactivity in Western blot for HIV-1 and HIV-2 may not indicate dual infection.
    Tedder RS; O'Connor T; Hughes A; N'jie H; Corrah T; Whittle H
    Lancet; 1988 Oct; 2(8617):927-30. PubMed ID: 2902381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tests produced by Organon Teknika for the diagnosis of antibodies to HIV-1 and HIV-2.
    Chantrain C
    Przegl Epidemiol; 1992; 46(1-2):3-10. PubMed ID: 1475387
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthetic peptide immunoassay for diagnosis of HIV 2 infection.
    Soriano V; Tor J; Ribera A; Martin J; Foz M
    Vox Sang; 1989; 57(3):222. PubMed ID: 2575825
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of the antigenic structure of human immunodeficiency virus using synthetic peptides].
    Ivanov VS; Chikin LD; Suvorova ZK; Kozhich AT; Ivanov VT
    Bioorg Khim; 1992 Jun; 18(6):784-93. PubMed ID: 1384509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2.
    de Wolf F; Meloen RH; Bakker M; Barin F; Goudsmit J
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1261-7. PubMed ID: 1710645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-2 infection in South Africa.
    Lyons SF; Smith AN; McGillivray GM; Schoub BD
    Trans R Soc Trop Med Hyg; 1988; 82(5):757. PubMed ID: 3252597
    [No Abstract]   [Full Text] [Related]  

  • 14. Carrier bound synthetic oligopeptides in ELISA test systems for distinction between HIV-1 and HIV-2 infection.
    Modrow S; Höflacher B; Gürtler L; Deinhardt F; Wolf H
    J Acquir Immune Defic Syndr (1988); 1989; 2(2):141-8. PubMed ID: 2467975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-colour combination enzyme-linked immunosorbent assay for the simultaneous detection of HBV and HIV infection.
    Porstmann T; Nugel E; Henklein P; Döpel H; Rönspeck W; Pas P; von Baehr R
    J Immunol Methods; 1993 Jan; 158(1):95-106. PubMed ID: 8429220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a procedure starting with an HIV-I/HIV-2 mixed EIA.
    Chou MJ; Chen HL; Lin HC; Lin CC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 Nov; 23(4):291-301. PubMed ID: 1983137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic peptides in the diagnosis of HIV infection.
    Alcaro MC; Peroni E; Rovero P; Papini AM
    Curr Protein Pept Sci; 2003 Aug; 4(4):285-90. PubMed ID: 14529535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenicity of nine synthetic peptides of human immunodeficiency virus].
    Mao P; He H; Hong S
    Zhonghua Nei Ke Za Zhi; 1997; 36(2):105-7. PubMed ID: 9812570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.
    Wang JJ; Steel S; Wisniewolski R; Wang CY
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6159-63. PubMed ID: 2426711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific synthetic peptides for detection of and discrimination between HIV-1 and HIV-2 infection.
    Broliden PA; Rudén U; Ouattara AS; de Thé G; Sølver E; Trojnar J; Wahren B
    J Acquir Immune Defic Syndr (1988); 1991; 4(10):952-8. PubMed ID: 1679844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.